Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41

Jin, Y. ; Giri, C. ; Klutch, M.J. ; Shepp, D. ; Wright, S.E.

Amsterdam : Elsevier
ISSN:
0264-410X
Keywords:
Immunogenicity ; fusion protein
Source:
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
Topics:
Medicine
Type of Medium:
Electronic Resource
URL:
_version_ 1798291733685993474
autor Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
autorsonst Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
book_url http://dx.doi.org/10.1016/0264-410X(93)90095-F
datenlieferant nat_lic_papers
fussnote To produce a vaccine against human immunodeficiency virus-1 with improved immunogenicity, the transmembrane and cytoplasmic tail regions of human immunodeficiency virus-1 were replaced with those of the Vesicular Stomatitis Virus glycoprotein, and cloned into vaccinia virus. This recombinant vaccinia virus, vvE13, was compared to one expressing full length envelope gp160, vvE1. Env products of both were located on the cell surface. Antibody response, lymphocyte proliferation and cytotoxicity were better with vvE13 than with vvE1 inoculated mice.
hauptsatz hsatz_simple
identnr NLZ185510922
issn 0264-410X
journal_name Vaccine
materialart 1
package_name Elsevier
publikationsort Amsterdam
publisher Elsevier
reference 11 (1993), S. 1280-1282
schlagwort Immunogenicity
fusion protein
search_space articles
shingle_author_1 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
shingle_author_2 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
shingle_author_3 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
shingle_author_4 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
shingle_catch_all_1 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
Immunogenicity
fusion protein
Immunogenicity
fusion protein
0264-410X
0264410X
Elsevier
shingle_catch_all_2 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
Immunogenicity
fusion protein
Immunogenicity
fusion protein
0264-410X
0264410X
Elsevier
shingle_catch_all_3 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
Immunogenicity
fusion protein
Immunogenicity
fusion protein
0264-410X
0264410X
Elsevier
shingle_catch_all_4 Jin, Y.
Giri, C.
Klutch, M.J.
Shepp, D.
Wright, S.E.
Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
Immunogenicity
fusion protein
Immunogenicity
fusion protein
0264-410X
0264410X
Elsevier
shingle_title_1 Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
shingle_title_2 Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
shingle_title_3 Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
shingle_title_4 Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
timestamp 2024-05-06T08:37:19.521Z
titel Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
titel_suche Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
To produce a vaccine against human immunodeficiency virus-1 with improved immunogenicity, the transmembrane and cytoplasmic tail regions of human immunodeficiency virus-1 were replaced with those of the Vesicular Stomatitis Virus glycoprotein, and cloned into vaccinia virus. This recombinant vaccinia virus, vvE13, was compared to one expressing full length envelope gp160, vvE1. Env products of both were located on the cell surface. Antibody response, lymphocyte proliferation and cytotoxicity were better with vvE13 than with vvE1 inoculated mice.
topic WW-YZ
uid nat_lic_papers_NLZ185510922